Detalhe da pesquisa
1.
Efficacy and Safety of the Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma: Results from an Open-Label, Single-Arm, Multicenter Phase 3 Study.
Ann Surg Oncol
; 2024 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38704501
2.
Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial.
Lancet Oncol
; 24(3): 213-227, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36796394
3.
ASO Visual Abstract: Efficacy and Safety of Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma: Results from an Open-Label, Single-Arm, Multicenter, Phase 3 Study.
Ann Surg Oncol
; 2024 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38789613
4.
Percutaneous hepatic perfusion with melphalan in uveal melanoma: A safe and effective treatment modality in an orphan disease.
J Surg Oncol
; 117(6): 1170-1178, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29284076
5.
Quality of life after melphalan percutaneous hepatic perfusion for patients with metastatic uveal melanoma.
Melanoma Res
; 34(2): 193-197, 2024 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38051786
6.
Liver resection for metastatic uveal melanoma: experience from a supra-regional centre and review of literature.
Melanoma Res
; 33(1): 71-79, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36409208
7.
Comparison of three-weekly and six-weekly pembrolizumab United Kingdom prescribing practice for advanced and resected melanoma.
Eur J Cancer
; 194: 113344, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37804771
8.
Chemosaturation with percutaneous hepatic perfusion of melphalan for metastatic uveal melanoma.
Melanoma Res
; 32(2): 103-111, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35254333
9.
The clinical features and management of testicular germ cell tumours in patients aged 60 years and older.
BJU Int
; 108(11): 1794-9, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21627751
10.
Late relapse (>2 years) on surveillance in stage I non-seminomatous germ cell tumours; predominant seminoma only histology.
BJU Int
; 106(11): 1648-51, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20735393
11.
The 111 Study: A Single-arm, Phase 3 Trial Evaluating One Cycle of Bleomycin, Etoposide, and Cisplatin as Adjuvant Chemotherapy in High-risk, Stage 1 Nonseminomatous or Combined Germ Cell Tumours of the Testis.
Eur Urol
; 77(3): 344-351, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31901440
12.
Outcome of Men With Relapses After Adjuvant Bleomycin, Etoposide, and Cisplatin for Clinical Stage I Nonseminoma.
J Clin Oncol
; 38(12): 1322-1331, 2020 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31877087
13.
Salvage Chemotherapy With Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin for Relapsed Germ Cell Cancer.
Clin Genitourin Cancer
; 16(6): 458-465.e2, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30115544
14.
Outcome of Men With Relapse After Adjuvant Carboplatin for Clinical Stage I Seminoma.
J Clin Oncol
; 35(2): 194-200, 2017 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27893332
15.
Evaluation of immune infiltration in the colonic mucosa of patients with ipilimumab-related colitis.
Oncoimmunology
; 5(9): e1209615, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27757302
16.
Clinical activity and safety of Pembrolizumab in Ipilimumab pre-treated patients with uveal melanoma.
Oncoimmunology
; 5(5): e1143997, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-27467964
17.
Systemic immune-inflammation index predicts the clinical outcome in patients with metastatic renal cell cancer treated with sunitinib.
Oncotarget
; 7(34): 54564-54571, 2016 08 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-27409344
18.
Outcome and Biomarker Analysis from a Multicenter Phase 2 Study of Ipilimumab in Combination with Carboplatin and Etoposide as First-Line Therapy for Extensive-Stage SCLC.
J Thorac Oncol
; 11(9): 1511-21, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27296105
19.
A Randomised Phase 2 Study of AZD2014 Versus Everolimus in Patients with VEGF-Refractory Metastatic Clear Cell Renal Cancer.
Eur Urol
; 69(3): 450-6, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26364551
20.
Immunosuppression for ipilimumab-related toxicity can cause pneumocystis pneumonia but spare antitumor immune control.
Oncoimmunology
; 4(10): e1040218, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26451305